Solventum Corporation SOLV

89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Solventum Corporation (SOLV) P/E ratio

As of 25 September 2026, Solventum Corporation (SOLV) trades at a P/E ratio of 10.9×. Over the past ten years it has ranged from 6.8× (June 2024) to 36.0× (July 2025); the current reading is higher than 55% of that period. That is below the Medical Instruments & Supplies industry median of 34.2× and below the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 8.9× (63.06%)
FY2024 24.0× 134.03%
FY2023 10.3× 0.00%
FY2022 10.3× —

Quarterly

Period P/E ratio Change
Jun 2026 9.4× 18.00%
Mar 2026 8.0× (10.37%)
Dec 2025 8.9× 6.24%
Sep 2025 8.4× (75.99%)
10 more quarters

Against its own ten years

Low 6.8× High 36.0×
Ten-year median 10.1×
Current reading's percentile 55

P/E ratio against peers

Company P/E ratio
AVTR Avantor, Inc. compare n/m
BAX Baxter International Inc. compare n/m
SOLV Solventum Corporation 10.9×
COO The Cooper Companies, Inc. compare 18.9×
ATR AptarGroup, Inc. compare 22.1×
ALGN Align Technology, Inc. compare 25.5×
WST West Pharmaceutical Services, Inc. compare 47.1×
ALC Alcon compare 49.2×
RGEN Repligen Corporation compare 253×
Medical Instruments & Supplies industry median 34.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on SOLV